0
Es befinden sich keine Waren im Warenkorb !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > S100A8

S100A8

Brief Information

Name:S100 calcium binding protein A9
Target Synonym:Protein S100-A9,CAGB,MRP-14,S100 calcium-binding protein A9,p14,S100A9,S100 Calcium Binding Protein A9,Migration Inhibitory Factor-Related Protein 14,Leukocyte L1 Complex Heavy Chain,Calprotectin L1H Subunit,MRP14,CFAG,S100 Calcium-Binding Protein A9 (Calgranulin B),Calgranulin-B,60B8AG,MAC387,CGLB,L1AG,LIAG,MIF,NIF,Calgranulin B
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

Nach Produktstatus:
Nach Produktkategorie :
Nach Arten:
Nach Markierungen:
Nach Konjugaten:
Kat. Nr. Arten Produktbeschreibung Struktur Reinheit Merkmal
S18-H5112 Human Human S100A8 Protein, Tag Free
S18-H5112-structure
S18-H5112-sds
ACRO Quality

Synonym Name

S100A8,60B8AG,CAGA,CFAG,CGLA,CP-10,MRP8,NIF,P8

Background

S100 calcium binding protein A8 (S100-A8) is also kown as Cystic fibrosis antigen, Migration inhibitory factor-related protein 8 60B8AG, CAGA, CFAG, CGLA, CP-10, L1Ag, MA387, MIF, MRP8, NIF and P8, is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. Most S100 proteins are disulfide-linked homodimer, and is normally present in cells derived from the

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Tasquinimod ABR-215050; TASQ; ABR-5050 Phase 2 Clinical Active Biotech Ab Ovarian Neoplasms; Polycythemia Vera; Carcinoma, Renal Cell; Stomach Neoplasms; Prostatic Neoplasms, Castration-Resistant; Multiple Myeloma; Prostatic Neoplasms; Primary Myelofibrosis; Thrombocythemia, Essential Details
Tasquinimod ABR-215050; TASQ; ABR-5050 Phase 2 Clinical Active Biotech Ab Ovarian Neoplasms; Polycythemia Vera; Carcinoma, Renal Cell; Stomach Neoplasms; Prostatic Neoplasms, Castration-Resistant; Multiple Myeloma; Prostatic Neoplasms; Primary Myelofibrosis; Thrombocythemia, Essential Details

This web search service is supported by Google Inc.

totop

Nachricht schicken